Morning Homed Blood Pressure Trial in elderly hypertensive patients with olmesartan medoxomil compared to azilsarta
- Conditions
- Essential Hypertension
- Registration Number
- JPRN-UMIN000020471
- Lead Sponsor
- Daiichi-Sankyo Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Not provided
1. History of hypersensitivity to test drugs 2. Secondary hypertension 3. Grade 3 hypertension (SBP >= 180mmHg and/or DBP >= 110mmHg) 4. Pregnant, possible to pregnancy, or patients who desire pregnancy 5. Taking ARB or ACE inhibitors (excluding taking these drugs more than 3 months before obtaining informed consent) 6. Taking aliskiren fumarate 7. Having serious renal dysfunction (serum creatinine >= 3.0mg/dL) 8. Having serious liver dysfunction 9. Developed cerebral hemorrhage or cerebral infarction within one year before obtaining informed consent 10. Developed myocardial infarction within one year before obtaining informed consent 11. Had a treatment of malignant tumor within 5 years before obtaining informed consent 12. undergoing hemodialysis treatment 13. Any those the investigator or other researchers consider as unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method